Using median expression level as the cutoff value, we found that high SALL4 expression in lung cancer was significantly correlated with reduced relapse-free survival and overall survival (Figure 1c), suggesting that patients with high SALL4 expression have poorer survival advantage. This evidence concerns the gene SALL4 and lung carcinoma.